Trial Profile
Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD) (TEPTAU)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2022
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Acronyms TEPTAU
- 08 Sep 2022 Status changed from active, no longer recruiting to completed.
- 06 Nov 2019 According to European Clinical Trials Database record, trial is completed.
- 25 Sep 2019 Planned End Date changed from 1 Sep 2018 to 25 Nov 2019.